Analysis of glomerulosclerosis and atherosclerosis in lecithin cholesterol acyltransferase-deficient mice.
about
Cathepsin D, a lysosomal protease, regulates ABCA1-mediated lipid effluxThe farnesoid X-receptor is an essential regulator of cholesterol homeostasisLipoprotein X Causes Renal Disease in LCAT DeficiencyGenetic causes of high and low serum HDL-cholesterol.The HDL hypothesis: does high-density lipoprotein protect from atherosclerosis?Lecithin: cholesterol acyltransferase--from biochemistry to role in cardiovascular disease.Cholesterol efflux and atheroprotection: advancing the concept of reverse cholesterol transport.Effect of recombinant human lecithin cholesterol acyltransferase infusion on lipoprotein metabolism in mice.Metabolism, energetics, and lipid biology in the podocyte - cellular cholesterol-mediated glomerular injury.Nutrigenomic analysis of the protective effects of bilberry anthocyanin-rich extract in apo E-deficient mice.Cholestasis and hypercholesterolemia in SCD1-deficient mice fed a low-fat, high-carbohydrate diet.Two novel mutations of lecithin:cholesterol acyltransferase (LCAT) gene and the influence of APOE genotypes on clinical manifestationsIncreased plasma cholesterol esterification by LCAT reduces diet-induced atherosclerosis in SR-BI knockout mice.Genetic basis of atherosclerosis: insights from mice and humansLecithin:cholesterol acyltransferase deficiency protects against cholesterol-induced hepatic endoplasmic reticulum stress in mice.Lecithin:cholesterol acyltransferase: old friend or foe in atherosclerosis?Systemic and renal lipids in kidney disease development and progression.Treatment of dyslipidemia in chronic kidney disease: Effectiveness and safety of statins.Lecithin cholesterol acyltransferase: an anti- or pro-atherogenic factor?Recombinant human lecithin-cholesterol acyltransferase Fc fusion: analysis of N- and O-linked glycans and identification and elimination of a xylose-based O-linked tetrasaccharide core in the linker region.Lecithin: cholesterol acyltransferase expression has minimal effects on macrophage reverse cholesterol transport in vivo.Molecular biology of atherosclerosis.Revising the high-density lipoprotein targeting strategies - insights from human and preclinical studies.A novel in vivo lecithin-cholesterol acyltransferase (LCAT)-deficient mouse expressing predominantly LpX is associated with spontaneous glomerulopathy.Mechanism and Physiologic Significance of the Suppression of Cholesterol Esterification in Human Interstitial Fluid.The refined structure of nascent HDL reveals a key functional domain for particle maturation and dysfunction.The role of reverse cholesterol transport in animals and humans and relationship to atherosclerosis.Lecithin: cholesterol acyltransferase and atherosclerosis: another high-density lipoprotein story that doesn't quite follow the script.Clinical Implications of Lipid Genetics for Cardiovascular Disease.Beneficial effects of statins on the kidney.Lecithin:cholesterol acyltransferase deficiency increases atherosclerosis in the low density lipoprotein receptor and apolipoprotein E knockout mice.No aggravation of renal injury in apolipoprotein E knockout mice (ApoE(-/-)) after subtotal nephrectomy.Peroxisome proliferator-activated receptor beta/delta regulates very low density lipoprotein production and catabolism in mice on a Western diet.Hepatic ABCG5 and ABCG8 overexpression increases hepatobiliary sterol transport but does not alter aortic atherosclerosis in transgenic mice.Increased plasma HDL cholesterol levels and biliary cholesterol excretion in hamster by LCAT overexpression.Coordinated alteration of hepatic gene expression in fatty acid and triglyceride synthesis in LCAT-null mice is associated with altered PUFA metabolism.HDL Cholesterol Metabolism and the Risk of CHD: New Insights from Human Genetics.The role of paraoxonase 1 in regulating high-density lipoprotein functionality during aging.Novel Missense LCAT Gene Mutation Associated with an Atypical Phenotype of Familial LCAT Deficiency in Two Portuguese Brothers.Network analysis of coronary artery disease risk genes elucidates disease mechanisms and druggable targets.
P2860
Q28267787-8BD168B4-E8A9-481C-88AE-0225121C7016Q28513874-E24AEA63-C79F-4505-BC67-033809E4E032Q28550403-0F417B02-270C-4757-B302-E8D475558E74Q33993060-2375236E-6DDB-409C-9E07-422EF984EF10Q33993233-B6F61F3D-8E6E-4DD6-98AD-6692E021A941Q34021570-EB771E62-2DF6-4719-87A5-4FDD1C3F9DEBQ34155049-30634B6A-EAC3-4311-A62F-780D4F0BEB1EQ34214772-C43408F8-A25C-4614-84F5-12B6752E0012Q34336370-931EEED8-4114-4555-BEF4-919398E156DFQ34338682-D2F78B00-81CB-46F0-9B6D-6D0B9AEA74E1Q34569462-01996978-6DB4-4379-BAD2-45265B560F37Q35574596-6C3051EB-1DBD-4A74-8460-9DD4AC5ACF47Q35776623-EA6BBD4C-9E57-48A2-89CC-CBD1976C044BQ35975437-A9AE6F3B-7B57-4436-833D-08AEB1073CA8Q36017023-D758D808-C3A5-4F9B-9E4A-F969EF146751Q36145188-8B8D34C4-C6DC-4F04-9983-E2E9FC0BFA84Q37148885-8BF3B88B-2857-43B8-9116-6CF93CB1B876Q37195404-F08B0DA9-740E-4631-9472-A5F12F0DB449Q37224981-E528E703-E8CA-421F-AED8-DD9C59FA2893Q37350339-71B71252-A49C-4228-B204-0D69E9F4466AQ37485026-DEA7EE2D-E7BE-4E5F-AD21-877E2E999E73Q38125279-9434DDC0-D63E-4153-BC65-CD297F431AFCQ38239205-A85AB90D-1225-431E-8EDF-BAFC5A47E6AEQ41772991-AB590D07-222F-40AA-925B-B7D03703165AQ41985208-057DCDE1-59FB-4779-BA66-4F9BDC15E73DQ42152420-1CDEA7AC-22C3-4844-B4A9-1A84FB46403EQ42203593-5BD7F794-5357-434F-9F9E-E4B0F07C3371Q42540496-BDAC0B2E-E273-4673-BA43-CAE5AB4A9EE5Q42575072-501986E0-2B5F-498E-9645-5F1B837A1165Q43010667-B9024929-15E2-4343-AD91-D630EFBB9A83Q43806634-A15CF26A-62B1-4810-A7C2-ED723293A320Q44758536-2A4A52FF-CE3D-4B63-976C-50F9C1C7AA8BQ44786921-52AB65B5-78CF-4B72-8E7D-DD9129F2CDB2Q44814610-9AC83808-9FF1-4881-8EF5-AD7EE0E6701DQ44976547-D02B765E-723B-436A-8576-55F243B13198Q46654994-007F3C3B-3332-4617-8488-E05279F3AE83Q47657807-86CBF4D3-18A6-4733-88D7-8C548A5ADF6DQ48024855-732298B2-4D0B-472B-A8A7-AAB137F07DD8Q49566406-A846CEE4-8F17-4083-AB13-0800685B9021Q50317765-E5EF2FCB-2279-4E32-8C3D-C276A42487F9
P2860
Analysis of glomerulosclerosis and atherosclerosis in lecithin cholesterol acyltransferase-deficient mice.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
Analysis of glomerulosclerosis ...... cyltransferase-deficient mice.
@en
type
label
Analysis of glomerulosclerosis ...... cyltransferase-deficient mice.
@en
prefLabel
Analysis of glomerulosclerosis ...... cyltransferase-deficient mice.
@en
P2093
P2860
P356
P1476
Analysis of glomerulosclerosis ...... acyltransferase-deficient mice
@en
P2093
Blanchette-Mackie J
Brewer HB Jr
Costello R
Neufeld EB
Remaley AT
P2860
P304
15090-15098
P356
10.1074/JBC.M008466200
P407
P577
2001-02-07T00:00:00Z